university of michigan health system

(University of Michigan Health System) A new needle-less vaccine is highly effective and can be stored without refrigeration, University of Michigan studies in animals show.

The vaccine should also be safer to administer than existing hepatitis B vaccines and effective with only two immunizations.

The technique, a nanoemulsion given in the nose, is a step closer to human trials, possibly within a year.

Hepatitis B kills an estimated 1 million people annually.

(University of Michigan Health System) Research from the University of Michigan Health System suggests that many students with food allergies aren't taking the threat of a reaction seriously enough, or are regularly in environments where they could not be properly treated during an emergency.

(University of Michigan Health System) A new study hints that people who have both alcohol problems and sleep problems -- which often occur together -- might be helped by an epilepsy drug.

The study, which is small but was placebo-controlled, opens the door for further research on how to help alcohol-dependent people escape the Catch-22 of insomnia and drinking that often stands in the way of their recovery.

(University of Michigan Health System) Researchers have pinpointed a gene mutation that accounts for a previously unidentified form of hearing loss.

University of Michigan and other scientists found the same mutation in two unrelated families, indicating the mutation may be ancient and not particularly rare.

Future research may find that it affects others who have an unexplained family history of hearing loss. Genes are likely involved in as many as 50 percent of people with hearing loss.

(University of Michigan Health System) Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival.

The finding could one day lead to a test that would help determine who needs more aggressive treatment.

(University of Michigan Health System) Every year, more than 115 million patients enter emergency rooms at hospitals around the nation.

And more than three-quarters of them leave with an impression of what happened -- or what should happen next -- that doesn't match what their emergency care team would want.

(University of Michigan Health System) Relatively new drugs now help some patients, but not others, with the most common form of multiple sclerosis.

That may be because patients with the same symptoms experience different types of inflammation, suggests a new study in animals from the University of Michigan.

If the differences are found in people, future treatments may be tailored to specific subtypes of the disease.

(University of Michigan Health System) Nearly one in 10 obstetricians in a new study has considered giving up obstetric practice because of the emotional toll of stillbirths and infant deaths.

Three-quarters of the 804 obstetricians who responded to a survey by researchers at the University of Michigan Health System reported that the experience took a large emotional toll on them personally.

(University of Michigan Health System) For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke, but bleeding risks and a limited time window for treatment have held it back.

Now, a new study reveals why tPA has these limitations and gives tantalizing evidence about how those problems might be overcome, if a stroke victim first takes a drug currently used to treat leukemia.

(University of Michigan Health System) University of Michigan scientists have identified key steps in breast-tissue cell division that go awry when CHFR's action is low or absent.

The gene's expression is missing in more than a third of breast cancers. The findings could make it possible to identify which patients are more likely to benefit from taxanes, a class of widely used cancer drugs which includes paclitaxel and docetaxel.